• Isabel Fox

    Isabel
    Fox

    Isabel Fox is a mother, wellness coach, Peloton enthusiast and one of just a handful of female General Partners in the UK. Prior to founding Luminous Ventures, Isabel was head of Venture Capital at White Cloud Capital where she focused on early stage investments in life sciences and healthcare.  With a background in investment banking and private equity turnarounds, Isabel founded and exited two corporate communications firms focused on the route to exit, co-founded two software start-ups (one exit) and been an active angel investor in the UK and US. She has worked in New York, San Francisco and London.  At Luminous Ventures, Isabel has the opportunity to invest in visionary founders with breakthrough technologies, and backing deep-tech and science that matters.  

  • Lomax Ward

    Lomax
    Ward

    Max was previously a healthcare and life science investor at White Cloud Capital, making venture and growth capital investments in Europe and Asia across a range of indications, technologies and services.  Having graduated from the University of Cambridge, Max started out as a corporate lawyer at Slaughter and May in London, Milan and Tokyo, sitting in the TMT and IP group.  There he worked on, among other things, technology IPOs and M&A, giving him a taste for the commercial and investment side.  His experience in intellectual property and regulation is particularly useful for the deep technology companies in which Luminous invests.  Outside of the office, Max is often to be found trail running in the mountains or (where he can't get away) the Surrey Hills.

  • John Spindler

    John
    Spindler

    Johns has a long background in the UK VC space and has a well earned reputation from his success. In parallel to working with Luminous, John will be running his own Seed fund, AI Seed. John has sat on both sides of the fence as both entrepreneur and investor. On the investing side, John is the former CEO of Capital Enterprise, co-founded the London Co-investment Fund and the Capital List, and was also  Investor Director at Basestone.

  • AJ

    Alexander
    Jan

    Alexander loves investing in the deep tech sector as he sees it as a return to his roots and that of venture capital. Alexander studied Engineering, Com Sci & Biotech for his undergrad in Australia and went on to conduct research at a cyclic particle accelerator in Canada before returning to complete a Masters of International Business. Whilst studying, Alexander worked with his TTO to spin out a number of technologies as well as co-founding an agri-biotech company in Thailand. After graduating, Alexander worked all over the world, including San Francisco, New York, Cambridge and Geneva, where he advised companies, government agencies and investors across a number of different areas - two relevant highlights for deep tech include Alexander co-founding a £140m patent fund and also developing a biotech hedge fund. In his spare time, Alexander runs his own quant fund, is the full-time EA to our Venture Canine Heidi, attempts to do some ultras and generally geek out when he’s not eating brunch or travelling.

  • James Joll

    James
    Joll

    On graduating from Oxford, James Joll joined the Financial Times eventually writing the Lex column before joining N.M.Rothscild & Sons where he was a director in the corporate finance department for ten years. He then joined Pearson plc acting as CFO for the last eleven years of his career. Thereafter he pursued a portfolio existence being chairman of AIB Asset Management and a non-executive director of a number of companies, including Equitas, the Lloyds pre 1992 reinsurance vehicle. He remains chairman of the trustees of the Pearson pension plan and paints in oils in the week-end.

  • Peter Crane

    Peter
    Crane

    Peter is a scientist discovering the potential of technology to disrupt traditionally siloed and deeply technical scientific industries. Despite his pivot away from his background in therapeutics, he still appraises deep technology platforms with the same rigour common to the biopharma industry. Whilst the inflections in deep tech may be different to therapeutics, a commitment to quality science, a thorough understanding of the patient or customer need, and a clear capital efficient plan to execute are commonalities. He currently works in corporate strategy at Synthace, and before this was working in healthcare investment roles and with deep technology start-up accelerators. He has a DPhil in Chemical Biology from Oxford University, a master’s in chemistry (top of year) from Warwick Uni and experience in biopharma R&D. Outside of work, Peter is a huge animal lover, his favourite animals being the Beagle and as per his namesake, the Heron. He is also passionate about spending time outdoors and as such loves spending his summers surfing.

  • Csaba Konkoly

    Csaba
    Konkoly

    Csaba has over two decades of investment experience in both the hedge fund and venture capital worlds. Prior to joining Luminous, Csaba founded Tiller Partners a Los Angeles-based venture capital firm that focuses on seed, early-stage venture and late-stage venture investments. Prior to that he was Partner and Co-CIO at the global macro hedge fund Commonwealth Opportunity Capital where he focused on asset allocation and risk management. Before that, he was co-founder of GATKO Partners, a global, top-down equity hedge fund with offices in London and Singapore. He holds an M.Sc. in Economics from the University of Budapest and attended the MBA Program at the New York University Stern School of Business.

  • Carly Minsky

    Carly
    Minsky

    Carly has a background as a technology journalist, writer and editor focusing on deep tech and scientific research. She has written about diverse topics including quantum technologies beyond computers, “smart” biotech research labs, blockchain forensics for anti-money laundering, and the challenges of investing in recreational tech for the elderly. Most recently she was a senior reporter and founding member at Sifted, a publication which spun out of the Financial Times to focus on European innovation and startups. She has a particular interest in responsible innovation and the social impact of emerging technologies.

  • Patricia Canāl

    Patricia
    Cañal

    Patricia was previously a manager at Accenture Strategy leading on international digital transformation projects and more recently has worked with startup accelerators such as Wayra and PUBLIC. Patricia has a Bachelors degree in Psychology with a specialism in neuroscience, a MSc in Organisational Behaviour, and is currently pursuing an MBA at London Business School. Outside of work Patricia's greatest passion is travel, and she is an experienced yogi and avid foodie.

  • Heidi

    Heidi

    Heidi likes long slow walks and giving people hugs especially if they have brought her treats. When not in the office, she likes to steal balls and occasionally sit on smaller dogs.

craig hadean
Craig Beddis, CEO, Hadean

I have been fortunate to have known Isabel Fox for almost 10 years. Isabel is one of the most connected people I know with a vast network of business and investment contacts. Isabel's understanding and support of early stage companies is fantastic, I would have no hesitation in recommending her to any entrepreneur or company looking for investment or strategic marketing support.